Indonesia: cold and cough remedies market revenue 2029

The revenue in the 'Cold & Cough Remedies' segment of the otc pharmaceuticals market in Indonesia was forecast to continuously increase between 2024 and 2029 by in total 349.6 million U.S. dollars (+53.11 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 1 billion U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the 'Cold & Cough Remedies' segment of the otc pharmaceuticals market was continuously increasing over the past years.

Find further information concerning the revenue in the otc pharmaceuticals market in Canada and the revenue in the 'Analgesics' segment of the otc pharmaceuticals market in Italy.

The Statista Market Insights cover a broad range of additional markets.

Revenue of the cold and cough remedies market in Indonesia from 2020 to 2029 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Citation formats